Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice

被引:55
作者
Li, Chuan [1 ]
Liu, Feng [2 ]
Liang, Mifang [2 ]
Zhang, Quanfu [1 ]
Wang, Xiaofang [1 ]
Wang, Tao [2 ]
Li, Jiandong [1 ]
Li, Dexin [1 ]
机构
[1] China CDC, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing 100052, Peoples R China
[2] China CDC, State Key Lab Infect Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 100052, Peoples R China
关键词
Hantaviruses; HTN-VLPs; Vaccine; VIRUS-LIKE PARTICLES; T-LYMPHOCYTE RESPONSES; HEMORRHAGIC-FEVER; RENAL SYNDROME; HEPATITIS-B; VACCINE; IMMUNIZATION; ANTIBODY; PROTEIN; CHINA;
D O I
10.1016/j.vaccine.2010.04.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A safe and effective hantavirus vaccine is highly desirable since hantaviruses are distributed worldwide and cause an acute and often fatal disease (hemorrhagic fever with renal syndrome, HFRS). Virus-like particles (VLPs) displaying functional viral proteins could provide effective vaccines against a few viruses, but their ability to induce hantavirus-specific immune response has not been adequately investigated. To measure the immunogenicity of Hantaan virus-like particles (HTN-VLPs) vaccine, we generated recombinant HTN-VLPs by co-expressing Hantaan virus nucleocapsid (N) protein and glycoproteins (Gn and Gc) in Chinese hamster ovary (CHO) cells. We compared intramuscular versus subcutaneous administration of HTN-VLPs for the ability to induce specific immune response against Hantaan virus infection. Mice that received both intramuscular and subcutaneous immunizations of HTN-VLPs were sufficiently stimulated specific antibody response against Hantaan virus N protein and glycoproteins, which was comparable to Chinese commercial inactivated bivalent hantaviruses vaccine. Moreover, vaccination with HTN-VLPs also resulted in the induction of higher levels of specific cellular response to N protein than that of inactivated vaccine. Our results provide an important insight towards the development of hantaviruses-like particles as a potential candidate vaccine for the control and prevention of hantaviruses infection. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4294 / 4300
页数:7
相关论文
共 33 条
  • [1] Boisgerault Florence, 2002, Expert Rev Vaccines, V1, P101, DOI 10.1586/14760584.1.1.101
  • [2] Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax®)
    Cho, HW
    Howard, CR
    [J]. VACCINE, 1999, 17 (20-21) : 2569 - 2575
  • [3] Virus-like particles as HIV-1 vaccines
    Doan, LX
    Li, M
    Chen, CY
    Yao, QZ
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2005, 15 (02) : 75 - 88
  • [4] Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
    Greenstone, HL
    Nieland, JD
    de Visser, KE
    De Bruijn, MLH
    Kirnbauer, R
    Roden, RBS
    Lowy, DR
    Kast, WM
    Schiller, JT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) : 1800 - 1805
  • [5] Hjelle Brian, 2002, Expert Rev Vaccines, V1, P373, DOI 10.1586/14760584.1.3.373
  • [6] Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing hantavirus structural genes in hamsters
    Kamrud, KI
    Hooper, JW
    Elgh, F
    Schmaljohn, CS
    [J]. VIROLOGY, 1999, 263 (01) : 209 - 219
  • [7] Human recombinant neutralizing antibodies against Hantaan virus G2 protein
    Koch, J
    Liang, MF
    Queitsch, I
    Kraus, AA
    Bautz, EKF
    [J]. VIROLOGY, 2003, 308 (01) : 64 - 73
  • [8] DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection
    Koletzki, D
    Schirmbeck, R
    Lundkvist, Å
    Meisel, H
    Krüger, DH
    Ulrich, R
    [J]. JOURNAL OF BIOTECHNOLOGY, 2000, 84 (01) : 73 - 78
  • [9] Hantavirus infections and their prevention
    Krüger, DH
    Ulrich, R
    Lundkvist, Å
    [J]. MICROBES AND INFECTION, 2001, 3 (13) : 1129 - 1144
  • [10] A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice
    Lee, BH
    Yoshimatsu, K
    Araki, K
    Okumura, M
    Nakamura, I
    Arikawa, J
    [J]. VACCINE, 2006, 24 (15) : 2928 - 2934